Vapreotide

A synthetic somatostatin analog used in medicine

Vapreotide
INN
Drug class
Routes of administration
Pregnancy category
Bioavailability
Metabolism
Elimination half-life
Excretion
Legal status
CAS Number
PubChem
DrugBank
ChemSpider
KEGG

Vapreotide is a synthetic somatostatin analog used primarily in the treatment of certain medical conditions such as esophageal varices and acromegaly. It mimics the action of natural somatostatin, a hormone that inhibits the release of several other hormones and secretions in the body.

Pharmacology

Vapreotide functions by binding to somatostatin receptors, which are G-protein-coupled receptors found throughout the body. This binding inhibits the secretion of various hormones, including growth hormone, insulin, and glucagon.

Mechanism of Action

The primary mechanism of action of vapreotide involves its interaction with somatostatin receptors, particularly the SSTR2 and SSTR5 subtypes. By activating these receptors, vapreotide reduces the release of growth hormone and other peptides, which can be beneficial in conditions like acromegaly and gastrointestinal bleeding.

Medical Uses

Vapreotide is used in the management of:

• Acromegaly: A condition characterized by excessive growth hormone production, leading to enlarged bones and tissues.
• Esophageal varices: Dilated veins in the esophagus that can bleed, often associated with liver cirrhosis.

Administration

Vapreotide is typically administered via intravenous or subcutaneous injection. The dosage and frequency depend on the specific condition being treated and the patient's response to therapy.

Side Effects

Common side effects of vapreotide include:

• Nausea
• Diarrhea
• Abdominal pain
• Injection site reactions

Related Pages

• Somatostatin
• Somatostatin receptor
• Acromegaly
• Esophageal varices

• 

  Vapreotide